Bicara Therapeutics is a clinical-stage company developing first-in-class biologics engineered to bring together the precision of targeted therapy and the power of immunotherapy. The company's dual-action biologics are designed to deliver an immunomodulatory payload directly to the tumor microenvironment to ramp up immune cell activity, potentially offering long-lasting efficacy.

Biotechnology

Bicara Therapeutics

Claire Mazumdar

David Raben

Angela Windt

Marie Bonneau

John Maraganore

Ryan Cohlhepp

Rachel Salazar

Ivan Hyep

Clinical Operations and Development

Advisory and Governance

Regulatory and Compliance

Leadership Team

Bicara Therapeutics

Org chart

Teams

Clinical Operations and Development

Advisory and Governance

Regulatory and Compliance

Leadership Team

Similar companies